United Therapeutics diskutieren
United Therapeutics
WKN: 923818 / Symbol: UTHR / Name: Utd Therapeut / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
464,90 €
0,02 %
United Therapeutics (UTHR) had its price target raised by Royal Bank Of Canada from $587.00 to $643.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by Oppenheimer Holdings, Inc. from $575.00 to $600.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by HC Wainwright from $525.00 to $600.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by UBS Group AG from $655.00 to $705.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by Cantor Fitzgerald from $525.00 to $625.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by TD Cowen from $575.00 to $660.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by HC Wainwright from $600.00 to $660.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) is now covered by Raymond James Financial, Inc.. They set an "outperform" rating and a $700.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target lowered by Royal Bank Of Canada from $707.00 to $701.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its "buy" rating reaffirmed by TD Cowen.
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by Royal Bank Of Canada from $701.00 to $704.00. They now have an "outperform" rating on the stock.
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by JPMorgan Chase & Co. from $685.00 to $687.00. They now have an "overweight" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Neueste Beiträge
Mizuho in Advanced Micro Devices Inc. diskutieren